YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms
Phase 1
Completed
- Conditions
- Nicotine WithdrawalTobacco Abstinence
- Interventions
- Device: tDCS, prefrontal cortex and parietal cortex
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 60
- Registration Number
- NCT01567982
- Locations
- 🇺🇸
1 Church Street, Room 729, New Haven, Connecticut, United States
Zonisamide for Heavy Drinkers With Bipolar Disorder
Phase 2
Terminated
- Conditions
- Alcohol Use DisordersBipolar Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 3
- Registration Number
- NCT01566370
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use
Not Applicable
Completed
- Conditions
- Serious Mental Illness
- Interventions
- Behavioral: Community ConnectorBehavioral: Peer Recovery MentorBehavioral: Peer Case Manager
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2015-01-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 285
- Registration Number
- NCT01566513
- Locations
- 🇺🇸
Yale Psychiatric Hospital, New Haven, Connecticut, United States
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 12
- Registration Number
- NCT01561833
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
Phase 2
Terminated
- Conditions
- Cryptococcal Infection Disseminated
- Interventions
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT01562132
- Locations
- 🇰🇪
Family AIDS Care and Education Services, Sindo, Nyanza, Kenya
Reducing Obesity and Type 2 Diabetes in High Risk Youth
Phase 2
Completed
- Conditions
- ObesityType 2 Diabetes
- Interventions
- Behavioral: HEALTH[e]TEENBehavioral: HEALTH[e]TEEN + CST
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 384
- Registration Number
- NCT01560676
- Locations
- 🇺🇸
Yale, New Haven, Connecticut, United States
FMRI of Stress and Addictive Disorders
Completed
- Conditions
- Cocaine DependenceOpioid DependenceAlcoholismPathological GamblersAdolescents
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 108
- Registration Number
- NCT01558973
- Locations
- 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States
Testing and Linkage to Care for Injecting Drug Users in Kenya
Not Applicable
Completed
- Conditions
- HIV InfectionHCV Coinfection
- Interventions
- Behavioral: POC CD4 and Peer Case ManagementDrug: HCV+PWIDBehavioral: Control - No intervention
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2018-10-05
- Lead Sponsor
- Yale University
- Target Recruit Count
- 9449
- Registration Number
- NCT01557998
- Locations
- 🇰🇪
National AIDS/STD Control Programme (NASCOP), Nairobi, Kenya
Internet Treatment for Weight Loss in Primary Care
Not Applicable
Completed
- Conditions
- OverweightObese
- Interventions
- Behavioral: Motivational InterviewingBehavioral: Treatment as usual with primary care physicianBehavioral: Nutritional Counseling
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Yale University
- Target Recruit Count
- 89
- Registration Number
- NCT01558297
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Not Applicable
Completed
- Conditions
- SteatohepatitisHypertriglyceridemiaNon Alcoholic Fatty Liver DiseaseAlanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
- Interventions
- Other: Omega diet
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 17
- Registration Number
- NCT01556113
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath